The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report

admin

The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:       Market Overview — What you need to know about MDR and more       Major M&A Deals by Sector       For Ophthalmology, Orthopedic & Spine, and Woundcare – Key Developments and Deals       Key …

Aspen Surgical Acquires Symmetry Surgical

admin

Aspen Surgical, a producer of disposable surgical products and a portfolio company of Audax Group, has purchased Symmetry Surgical, a maker of electrosurgery products, instruments and minimally invasive surgical devices, from Roundtable Healthcare Partners.  The acquisition diversifies Aspen’s offerings into electrosurgery including bipolar forceps and generators, along with instruments for other specialties.  Terms not announced.       Keywords: Healthcare …

Halma Purchases IZI Medical Products for $153.5m

admin

Halma plc, a $1.7b UK-based provider of safety, environmental and analysis, and medical technology solutions, has purchased IZI Medical Products, a maker of devices used in image-guided surgery, interventional oncology and interventional spine procedures.  IZI’s offerings include an automatic biopsy system and a vertebral compression fracture (VCF) treatment system.  IZI will operate as a standalone company within Halma’s healthcare sector …

CVS Acquires Signify Health for $8b

admin

CVS Health Corporation is buying Signify Health, a $773.4m provider of home and virtual healthcare services.  The acquisition adds a mobile network of 10,000 credentialed clinicians offering in-home evaluations of Medicare Advantage and Medicaid plan members.  The deal represents a shift in the drugstore chain’s traditional brick and mortar store foundation to home visits and remote care.  Last year, CVS announced …

Teleflex Acquires Standard Bariatrics for $170m

admin

Teleflex, a $2.8b producer of single-use devices for diagnostic, critical care and surgical applications, is buying Standard Bariatrics, a developer of a powered stapling technology for bariatric surgery.  Standard Bariatrics has commercialized its stapler platform which enables surgeons to place continuous staples in one firing, minimizing variations associated with multiple overlapping short-cartridge staple firings.  The device is used in sleeve …

Patient Square Capital to Acquire Hanger for $1.2b

admin

Hanger, Inc. (NYSE: HNGR), a $1.14b provider of orthotic and prosthetic (O&P) patient care services and devices, announced that it will be taken private by Patient Square Capital, a private investment firm.  Hanger operates 875 clinic locations nationwide and distributes branded and private label O&P devices. Deal value – $1.25b on sales of $1.14b (1.1x) and EBITDA of $68m(18.4x).   …

BD (Becton, Dickinson and Company) Completes $1.5b Acquisition of Parata Systems

admin

Parata Systems adds a portfolio of pharmacy automation solutions that reduce costs, enhance patient safety and improve patient experience for retail, hospital and long-term care pharmacies.  The pharmacy automation market is worth an estimated $600 million and is expected to grow approximately 10% annually to $1.5 billion in the U.S. alone over the next 10 years.  Parata’s offerings include vial …

OrthoPediatrics to Acquire Pega Medical

admin

OrthoPediatrics, a $98m producer of implants and devices that treat orthopedic conditions in children, is acquiring Canada-based Pega Medical, a developer of implant systems that treat bony deformities in children with osteogenesis imperfecta (brittle bone disease), for $33m.  The acquisition adds to OrthoPediatrics’ range of technologies addressing unique conditions in pediatric orthopedics.  Orthopediatrics acquired MD Orthopaedics, a producer of specialty …

Biosynth Carbosynth Acquires Aalto Bio Reagents

admin

  Biosynth Carbosynth, a provider of life science research products and contract manufacturing services, has purchased Ireland-based Aalto Bio Reagents, a supplier of biological materials serving the in-vitro diagnostic (IVD) and vaccine development markets.  In March 2022, Biosynth acquired vivitide, a provider of custom peptides and antibodies.  Biosynth is backed by private equity firms KKR and Ampersand Capital.  Terms not …

The Walden Group Releases Q1 2022 Strategic Healthcare M&A Report

admin

The Walden Group is pleased to provide access to its Q1 2022 Strategic Healthcare M&A Report, which includes:       Market Overview       Major M&A Deals by Sector       What the Leading CEOs are Saying       Performance of Leading Healthcare Companies       Analysis of More Than 50 Q1 M&A Transactions   …